People: Palatin Technologies Inc (PTN)

PTN on American Stock Exchange

0.65USD
18 Dec 2014
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.65
Open
$0.66
Day's High
$0.68
Day's Low
$0.65
Volume
42,119
Avg. Vol
120,729
52-wk High
$1.50
52-wk Low
$0.59

Search Stocks

Spana, Carl 

Brief Biography

Dr. Carl Spana, Ph.D., is President, Chief Executive Officer, Director of PALATIN TECHNOLOGIES, INC. He is co-founder of Palatin, has been our chief executive officer and president since June 14, 2000. He has been a director of Palatin since June 1996 and has been a director of our wholly-owned subsidiary, RhoMed Incorporated, since July 1995. From June 1996 through June 14, 2000, Dr. Spana served as an executive vice president and our chief technical officer. From June 1993 to June 1996, Dr. Spana was vice president of Paramount Capital Investments, LLC, a biotechnology and biopharmaceutical merchant banking firm, and of The Castle Group Ltd., a medical venture capital firm. Through his work at Paramount Capital Investments and The Castle Group, Dr. Spana co-founded and acquired several private biotechnology firms. From July 1991 to June 1993, Dr. Spana was a Research Associate at Bristol-Myers Squibb, a publicly-held pharmaceutical company, where he was involved in scientific research in the field of immunology. He has agreed to serve as a director of Microlin Bio, Inc., an emerging therapeutic and diagnostic company focusing on microRNA, upon consummation of its initial public offering, and was previously a member of the board of the life science company AVAX Technologies, Inc. Dr. Spana received his Ph.D. in molecular biology from The Johns Hopkins University and his B.S. in biochemistry from Rutgers University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
686,771 -- 258,909 1,163,080

Options Compensation

  Quantity Market Value
Exercisable 901,712 79,384.00
Unexercisable 137,250 15,563.00
Exercised -- --
Name Fiscal Year Total

John Prendergast

--

Carl Spana

1,163,080

Stephen Wills

1,058,110

Robert deVeer

--

Alan Dunton

--

Zola Horovitz

--
As Of 29 Jun 2013
Search Stocks